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Protein glycosylation impacts the development and function of innate immune cells. The glyco-
phenotypes and the glycan remodelling associated with the maturation of macrophages from 
monocytic precursor populations remain incompletely described. Herein, label-free PGC-LC-MS/MS 
was employed to profile with high resolution the N- and O-glycome associated with human monocyte-
to-macrophage transition. Primary blood-derived CD14+-monocytes were differentiated ex vivo in the 
absence of strong anti- and pro-inflammatory stimuli using a conventional seven-day granulocyte-
macrophage colony-stimulating factor differentiation protocol with longitudinal sampling. 
Morphology and protein expression monitored by light microscopy and proteomics validated the 
maturation process. Glycomics demonstrated that monocytes and macrophages display similar N-
glycome profiles, comprising predominantly paucimannosidic (Man1-3GlcNAc2Fuc0-1, 22.1%-30.8%), 
oligomannosidic (Man5-9GlcNAc2, 29.8%-35.7%) and α2,3/6-sialylated complex-type N-glycans with 
variable core fucosylation (27.6%-39.1%). Glycopeptide analysis validated conjugation of these glycans 
to human proteins while quantitative proteomics monitored the glyco-enzyme expression levels 
during macrophage differentiation. Significant inter-person glycome variations were observed 
suggesting a considerable physiology-dependent or heritable heterogeneity of CD14+-monocytes. 
Only few N-glycome changes correlated with the monocyte-to-macrophage transition across donors 
including decreased core fucosylation and reduced expression of mannose-terminating 
(paucimannosidic-/oligomannosidic-type) N-glycans in macrophages, while lectin flow cytometry 
indicated that more dramatic cell surface glycan remodelling occurs during maturation. The less-
heterogeneous core 1-rich O-glycome showed a minor decrease in core 2-type O-glycosylation, but 
otherwise remained unchanged with macrophage maturation. This high-resolution glycome map 
underpinning normal monocyte-to-macrophage transition, the most detailed to date, aids our 
understanding of the molecular makeup pertaining to two vital innate immune cell types and forms 





Complex carbohydrates (hereafter glycans) decorate and modulate the function of intra- and 
extracellular proteins in all eukaryotic species (Moremen, K.W., Tiemeyer, M., et al. 2012, Varki, A. 
2016). Glycoproteins are secondary gene products; while their polypeptide sequences can be 
predicted from the coding genes, this is not the case for the conjugated glycans that are produced by 
template-less pathways. In human and other mammals, glycoprotein biosynthesis entails a complex 
series of enzymatic processing steps involving timely interactions of nascent glycoproteins with the 
many glycoside hydrolases and glycosyltransferases residing in the secretory machinery (Aebi, M. 
2013). As a result, glycoproteins often display glycosylation signatures that accurately reflect the 
physiological state of the producing cell at the time of expression. 
This complex and dynamic biosynthesis makes glycoproteins ideal to relay chemical information within 
and between cells and tissues; transmittable information that is tuneable to allow cells to aptly 
respond to physiological, pathological and ecological cues. Hence, it is not surprising that 
glycoproteins are involved in a broad array of biological processes including cell proliferation, 
adhesion, differentiation and signalling, processes that are known to be vital for the human immune 
system (Lau, K.S., Partridge, E.A., et al. 2007, Lyons, J.J., Milner, J.D., et al. 2015, Ohtsubo, K. and Marth, 
J.D. 2006, Springer, S.A. and Gagneux, P. 2016). For example, protein glycans are recognised to 
facilitate communication between and within the innate and adaptive immune system by modulating 
the thresholds for receptor activation (Cerliani, J.P., Blidner, A.G., et al. 2017, Clark, M.C. and Baum, 
L.G. 2012, van Kooyk, Y. and Rabinovich, G.A. 2008), and are key molecules involved in pathogen 
recognition mediated by antigen presenting cells such as dendritic cells and macrophages (van Kooyk, 
Y. and Rabinovich, G.A. 2008). 
Surveillance of and response to microbial invasion by the innate immune system are processes 
contingent on a timely differentiation of circulating monocytes to more specialised effector cells 
including macrophages that are involved in tissue sensing, mobilisation of the adaptive immune 




marrow-derived monocytes form an abundant population of mononuclear phagocytes in circulation. 
Monocytes are now recognised to carry out complex and diverse roles including phagocytosis and 
antigen presentation in circulation and in peripheral tissues and lymphoid organs (Jakubzick, C.V., 
Randolph, G.J., et al. 2017). These functions add important nuances to the more classical view that 
monocytes also form an important reservoir of precursor cells that differentiate into various types of 
macrophages and dendritic cells upon appropriate chemical stimulation. The monocyte-derived 
macrophages, the focus of this study, are considered distinctly different from the embryonically-
derived self-replenishing macrophages residing in the peripheral tissues e.g. microglia in the brain, 
Kupffer cells in the liver and alveolar macrophages in the lung (Jakubzick, C.V., Randolph, G.J., et al. 
2017). Due to their diverse origins and tissue residence, macrophages form a highly heterogeneous 
and dynamic population of powerful effector cells of the innate immune system involved in pathogen 
elimination, embryonic development and tissue repair via multiple mechanisms e.g. phagocytosis and 
antigen presentation (Hirayama, D., Iida, T., et al. 2017, Italiani, P. and Boraschi, D. 2014). 
Both monocytes and macrophages express a spectrum of carbohydrate-recognising receptors that are 
known to be involved in phagocytosis of cells or, in the case of microbial pathogens, entire organisms, 
cellular debris or biomolecular complexes destined for phagocytosis by binding to terminal 
glycoepitopes presented by proteins or lipids. For instance, linkage-specific mannosyl- (Man-) or N-
acetylglucosaminyl- (GlcNAc-) containing glycoepitopes on certain pathogens e.g. Mycobacterium 
tuberculosis are known to induce their clearance via phagocytosis facilitated by dedicated endocytic 
receptors such as Toll-like receptors (TLRs) e.g. TLR2 and C-type lectin receptors e.g. the macrophage 
mannose receptor amongst many other lectin receptors expressed by macrophages (Queval, C.J., 
Brosch, R., et al. 2017). Macrophages are highly specialised and adapted to their immunological niche 
and adequately fine-tuned to react to environmental stimuli. This is facilitated by an array of cell 
surface-located sensing receptors that together with a diverse class of transmembrane glycoproteins, 
proteoglycans, glycosphingolipids and glycosaminoglycans form important components of the 




proteins play important and highly diverse roles in the innate immune system (Bax, M., García-Vallejo, 
J.J., et al. 2007, Nonaka, M., Ma, B.Y., et al. 2008). 
The monocyte-to-macrophage transition process involves a time-segregated differentiation phase and 
a subsequent polarisation/activation phase. Although community consensus is yet to be reached, the 
differentiation, which ex vivo takes 5-7 days, but presumably is significantly faster in vivo, is thought 
to be a definitive event whereas macrophage polarisation shows plasticity according to the array of 
context-dependent signals individual macrophages may sense and integrate (Italiani, P. and Boraschi, 
D. 2014). Herein, we specifically focused on detailing the molecular signatures associated with 
macrophage differentiation as opposed to the subsequent macrophage polarisation phase. The 
monocyte-derived macrophages are commonly grouped into different types and subtypes based on 
their polarisation status and phenotype; M1- (or “classically” activated) macrophages are present in 
inflammatory settings dominated by TLRs and interferon signalling. The activation of these “pro-
inflammatory” macrophages may be triggered by strong stimulants including a combination of 
granulocyte-macrophage colony-stimulating factor (GM-CSF) and infectious pro-inflammatory agents 
such as pathogenic lipopolysaccharides. The M1-macrophages are crucial to fight intruding pathogens 
such as M. tuberculosis (Walters, S.B., Kieckbusch, J., et al. 2013). In contrast, M2a-c-macrophages (or 
“alternatively” activated macrophages) are found in settings dominated by a TH2 (anti-inflammatory) 
response (Gleissner, C. 2012, Italiani, P. and Boraschi, D. 2014, Murray, P.J. 2017). The M1 and M2 
activation phenotypes differ from the non-activated M0-macrophages in their response to certain 
stimuli (Tarique, A.A., Logan, J., et al. 2015). 
Molecular-level characterisation of macrophage maturation has been a focus over the past decade 
using gene expression, proteomics and surface marker analyses (Court, M., Petre, G., et al. 2017, 
Eligini, S., Brioschi, M., et al. 2015, Geissmann, F., Manz, M.G., et al. 2010, Kraft-Terry, S.D. and 
Gendelman, H.E. 2011, Martinez, F.O., Gordon, S., et al. 2006, Martinez, F.O., Sica, A., et al. 2008, 




insights into the regulation associated with macrophage differentiation and polarisation. Relative to 
the uncommitted M0 phenotype, M1-macrophages display an altered expression of prostaglandin 
G/H synthase 2, tumour necrosis factor alpha, apolipoprotein L3, C-X-C motif chemokine 11, and 
interferon regulatory factor 5 (Mills, C.D., Kincaid, K., et al. 2000, Murray, P.J. 2017, Tarique, A.A., 
Logan, J., et al. 2015). Functionally-relevant alterations in protein glycosylation impacting the antigen 
receptor signalling and recognition events in the differentiation of human B cells and dendritic cells 
are also known to occur during immune cell differentiation (Bax, M., García-Vallejo, J.J., et al. 2007, 
Berger, R.P., Dookwah, M., et al. 2016, Giovannone, N., Antonopoulos, A., et al. 2018), and modulation 
of the expression levels and/or activity of several glycosylation enzymes i.e. glycosyltransferases and 
glycoside hydrolases during monocyte maturation into macrophages has repeatedly been reported 
(Delannoy, C.P., Rombouts, Y., et al. 2017, Kohro, T., Tanaka, T., et al. 2004, Trottein, F., Schaffer, L., 
et al. 2009). However, very limited biochemical literature is available to detail the actual protein 
glycosylation underpinning macrophage maturation (Delannoy, C.P., Rombouts, Y., et al. 2017, Zarif, 
J.C., Yang, W., et al. 2017), and a comprehensive time-resolved map of the N- and O-glycome 
signatures associated with monocyte differentiation to macrophages is still missing. To this end, we 
herein performed longitudinal whole cell N- and O-glycome profiling of the GM-CSF-induced transition 
of human CD14+-monocytes into macrophages at high-definition by mass spectrometry-based 
glycomics and accompanying proteomics, glycopeptide analysis, microscopy and lectin flow cytometry 






Material and Methods 
The chemicals and reagents used in this study were of analytical-grade or higher and were, if not 
stated otherwise, obtained from Sigma-Aldrich/Merck KGaA, Darmstadt, Germany. 
 
Source and isolation of human monocytes 
Buffy coats from healthy de-identified donors were provided by the Australian Red Cross (Sydney, 
Australia) with approval from the UTS Human Research Ethics Committee, Ref # ETH 19-3807. The age, 
gender and other donor information were not disclosed by the provider of the donor specimens. 
Peripheral blood mononuclear cells were isolated over Ficoll-Paque, and monocytes were isolated to 
purity (typically >95%) using positive CD14+ selection (Miltenyi Biotec, Sydney, Australia) as described 
(Walters, S.B., Kieckbusch, J., et al. 2013). Cells from a minimum of three different donors were used 
for all assays. CD14+-monocyte isolation and differentiation were carried out multiple times to conduct 
the various assays. 
 
Monocyte-to-macrophage differentiation 
Isolated CD14+-monocytes from three donors were resuspended in DMEM media (Thermo Fisher 
Scientific, Sydney Australia) supplemented with 10% foetal bovine serum (FBS), 100 U/mL penicillin, 
100 µg/mL streptomycin and 10 ng/mL GM-CSF, plated in 12 well plates at 106 cells/well and cultured 
for up to seven days. Cells from the three donors were plated separately for each time point allowing 
for donor-specific longitudinal monitoring (paired data points). Monocyte differentiation was 
monitored daily using a wide field light microscope (EVOS FL, Thermo Fisher Scientific) at 10X, 20X and 
40X magnification. Cells were harvested on day 0, 1, 3, 5 and 7 during differentiation after washing 
the adherent cells thoroughly with cold PBS. Cells were washed a further three times with PBS in 
attempts to remove all traces of any contaminating FBS, and finally resuspended in 500 µL PBS 
containing a cocktail of PierceTM protease and phosphatase inhibitors (Thermo Scientific). 
 




The monocyte-macrophage cell populations were harvested in PBS and washed with Hank’s balanced 
salt solution on day 0, 1, 3, 5 and 7 during monocyte differentiation. Changes in cell surface 
glycosylation were assessed using concanavalin A (ConA) CF™ 640R and wheat germ agglutinin (WGA) 
CF™ 405M (Biotium, Fremont, CA) as per the manufacturer’s instructions. The surface expression of 
glycoepitopes was measured on a Beckman Coulter CytoFLEX LX flow cytometer (Indianapolis, USA). 
Data was analysed using the FlowJo v10 software (FlowJo LLC, USA). 
 
Cell lysis and protein extraction 
Harvested cell populations (monocytes and maturing or fully mature macrophages) from each of the 
three donors were lysed in technical triplicates at each time point in 500 µL PBS containing a cocktail 
of PierceTM protease and phosphatase inhibitors (Thermo Scientific) with sonication using a Branson 
450 Digital Sonifier for 5-10 s at 38% output level on ice. Homogeneous cell lysates were obtained by 
adding 2% (w/v) sodium dodecyl sulfate (final concentration) to the samples which were then 
centrifuged for 20 min at 2,000g at 4°C. The supernatants containing the protein extracts of interest 
were transferred to new tubes for glycomics and proteomics analyses. While the protein extracts from 
all samples were profiled using glycomics, the technical replicates obtained at each time point were 
combined for quantitative proteomics and glycopeptide analysis. 
 
N- and O-glycan release and sample preparation 
Protein extracts (20 µg) were spotted onto an activated PVDF membrane, dried, stained and the N- 
and O-glycans sequentially released and processed as previously described (Jensen, P.H., Karlsson, 
N.G., et al. 2012). In short, the N-glycans were released using 10 U (1 μL) peptide:N-glycosidase F 
(Promega, Madison, WI) in PBS overnight at 37°C. The N-glycans were then reduced using 1 M sodium 
borohydride (final concentration) at 50°C, 3 h and desalted using a dual solid-phase extraction (SPE) 
procedure comprising sequential strong cation exchange-C18-SPE and Hypercarb-SPE. The N-glycans 




The O-glycans were subsequently released from the same protein spots by overnight incubation in 0.5 
M sodium borohydride in 50 mM aqueous potassium hydroxide (final concentrations) at 50°C. The 
reduced O-glycans were desalted as described for N-glycans and dissolved in 10 µL MilliQ water. The 
N- and O-glycans were profiled separately using porous graphitised carbon (PGC) LC-MS/MS. 
 
Protein denaturation and tryptic peptide generation 
For label-free proteomics, the protein extracts were first processed using methanol-chloroform 
precipitation (Wessel, D. and Flugge, U.I. 1984). The pellet was dissolved in 4 M urea in 50 mM 
triethylammonium bicarbonate (TEAB) (pH 8.5). Proteins were reduced and alkylated by the addition 
of 10 mM dithiothreitol (37°C, 30 min), 40 mM iodoacetamide (room temperature, 30 min in the dark), 
and then 20 mM dithiothreitol to quench the alkylation reaction (all final concentrations). Samples 
were diluted with 50 mM TEAB to reach concentrations below 1 M urea. Sequencing grade trypsin 
(Promega) was added in a 1:30 (w/w, enzyme/protein) ratio. Samples were incubated overnight at 
37°C and the reactions were stopped by acidification using trifluoroacetic acid. Peptides were desalted 
using Oligo R3-SPE clean up prior to proteomics (PerSeptive Biosystems, Framingham, MA). 
 
LC-MS/MS parameters, data analysis and statistics for glycomics profiling 
Glycomics profiling of both the N- and O-glycome was performed using our recently described PGC-
LC-MS/MS platform employing a post-column-makeup flow, which supplements methanol (57% v/v, 
final concentration) to the main LC solvents (Hinneburg, H., Chatterjee, S., et al. 2019). Briefly, glycans 
were separated on a capillary PGC-LC column (Hypercarb, 3 μm particle size, 180 μm I.D. x 100 mm, 
Thermo Scientific) heated to 50°C. For the N-glycan separation, the multi-step gradient made from 10 
mM aqueous ammonium bicarbonate (solvent A) and 10 mM ammonium bicarbonate in 70% (v/v) 
acetonitrile (ACN, solvent B) was 2.6% (v/v) B for 8 min, a linear increase to 13.5% (v/v) B over 2 min, 
to 37.3% (v/v) B over 55 min, and to 64% (v/v) B over 10 min, before the column was cleaned in 98% 




was used to deliver a constant column flow rate of 3 μL/min. For the O-glycan analysis, the gradient 
was 2.8-30% (v/v) B over 38 min before a linear ramp to 98% (v/v) B over 5 min was applied, followed 
by a 2 min column clean in 98% (v/v) B and column re-equilibration in 2.8% (v/v) B. 
A Velos linear ion trap (LTQ, Thermo Scientific) operating in negative ion polarity mode (HESI-II probe 
position B depth) was used for data acquisition with the following parameters: Capillary voltage of -
2.7 kV, capillary heating to 275°C, 3 microscans, 5 × 104 automatic gain control (AGC) (zoom 3.7 x 104) 
and a maximum accumulation time of 100 ms/scan. Resonance-activation collision-induced 
dissociation (CID) MS/MS of the top five most abundant precursor ions in each MS1 full scan was 
performed (2 × 104 AGC, 250 ms maximum accumulation time/scan). An precursor isolation window 
of 1.5-2 Th for CID-MS/MS with a normalised collision energy of 33%, an activation Q of 0.250 and an 
activation time of 10 ms was used for fragmentation. Dynamic exclusion was enabled with repeat 
counts set at a maximum of 5, repeat duration at 15 s and exclusion duration at 30 s. All spectra were 
acquired in profile mode. The MS1 spectra for the N-glycans were recorded in the range m/z 570–
2,000 while the smaller O-glycans were recorded using m/z 375-1,800. 
Spectral annotation was performed manually using Xcalibur v2.2 (Thermo Scientific). All glycans were 
identified based on their monoisotopic mass, CID-MS/MS fragmentation pattern and the relative 
abundance of the fragment ions  (Everest-Dass, A.V., Jin, D., et al. 2012, Harvey, D.J. 2005a, Harvey, 
D.J. 2005b, Thaysen-Andersen, M., Mysling, S., et al. 2009), and the relative and absolute PGC-LC 
retention time behaviour (Abrahams, J.L., Campbell, M.P., et al. 2018, Pabst, M. and Altmann, F. 2008, 
Palmisano, G., Larsen, M.R., et al. 2013). The observed glycans were further validated using knowledge 
of the human biosynthetic machinery and the expected structural relationships between the observed 
glycans (Trombetta, E.S. 2003, Varki A, C.R., Esko JD, et al., editors. 2015-2017). The latest symbol 
nomenclature was used for the graphical representations of the glycans (Varki, A., Cummings, R.D., et 
al. 2015). Supplementary data 1 is a compilation of annotated fragment spectra of all reported 
glycans. For relative glycan quantitation, the area-under-the-curve of the monoisotopic peak of 




using Skyline (64-bit) v3.7.0.11317 (Ashwood, C., Lin, C.H., et al. 2018), see Extended experimental 
section for settings. 
The quantitative glycan data was analysed and visualised using the language and environment for 
statistical computing R v3.4.2 (https://www.R-project.org/) and Microsoft Excel 2013, respectively. 
Data points have generally been plotted as the mean of technical and/or biological replicates as 
indicated for the individual experiments. Error bars indicate their standard deviation. The mean 
relative abundance values of N-glycans were plotted as a heat map using the R-package pheatmap 
v1.0.10. Paired, two-tailed Student’s T-tests were used for statistical testing of the data; p-value 
correction for multiple testing was applied when appropriate according to Benjamini and Hochberg 
(Benjamini, Y.a.H., Y. 1995); p < 0.05 was used as the minimum significance threshold. For further 
details of the statistical testing, see SI. The R code is available upon request. 
 
LC-MS/MS parameters, data analysis and statistics for proteomics and glycopeptide analysis 
(Glyco-)peptides were analysed using nano-flow reversed-phase liquid chromatography using a 
Dionex UltiMate 3000 RSLCnano system (Thermo Scientific) coupled online to a Q Exactive HF-X Hybrid 
Quadrupole-Orbitrap mass spectrometer (Thermo Scientific). Peptides (1.5 μg) were loaded under 
isocratic conditions on a C18 nano-trap column (Halo-C18, 160 Å, 2.7 µm, 100 µm x 3.5 cm, Advanced 
Materials Technology, Wilmington, DE) using 0.1% (v/v) aqueous formic acid (FA) (solvent A) delivered 
by the loading pump at a flow rate of 5 µL/min. The C18 nano-scale pre-column cycle was connected 
after 5.9 min by a valve switch. The C18 nano-scale analytical column (Halo-C18, 160 Å, 2.7 µm, 100 
µm x 30 cm) was heated to 45°C. Solvent B was 0.1% (v/v) FA in 99 % (v/v) ACN. A constant flow rate 
of 600 nL/min was used. The gradient was as follows: 6 min 2% (v/v) B, followed by an increase to 30% 
(v/v) B over 100 min, to 50% (v/v) B over 18 min, and a 1 min increase to 95% (v/v) B, which was held 
for 9 min before dropping to 2% (v/v) B over 1 min to re-equilibrate the column for 15 min. The total 
run time was 150 min. The pre-column and analytical column cycles were disconnected by a valve 




The mass spectrometer was operated in positive ion mode. The source was equipped with stainless 
steel nano-bore emitters (Thermo Scientific). MS parameters were as follows: Source voltage (2.7 kV); 
capillary temperature (250°C); sheath gas flow, auxiliary gas flow, and sweep gas flow were set to zero. 
Full MS1 scan spectra were acquired between m/z 350-1,800 at a resolution of 60,000 using profile 
mode; the AGC target was set to 3 x 106; and maximum injection time was set to 50 ms. Fragment ion 
(MS/MS) spectra were obtained of the top 20 most intense precursor ions (charge state Z ≥ 2 and 
signal intensity ≥ 10,000 AGC) by subjecting isolated precursors to higher-energy collisional 
dissociation (HCD). Resolution was set at 15,000, AGC at 2 x 105, the maximum injection time at 28 ms 
and fixed first mass at m/z 100. The normalised collision energy was set to 30. The precursor isolation 
window was 1.2 Th. Isotopes were excluded and dynamic exclusion was set to 30 s. 
Label-free identification and quantitation was performed using MaxQuant v1.6.3.4 and statistical 
analysis using Perseus v1.6.2.2 (Cox, J. and Mann, M. 2008) by searching against the human proteome 
(20,404 reviewed entries; downloaded from UniProtKB on April 4, 2019) and bovine proteome (6,006 
reviewed entries; downloaded April 18, 2019). Potential contaminants and decoy hits (known false 
positives) were excluded from the lists of reported proteins. Significant alterations in the protein 
expression were identified using one-way ANOVA (multiple sample testing) and a significance 
threshold of p < 0.05. Only significantly regulated proteins were used as input for the pathway analysis 
using DAVID v6.8 (Huang da, W., Sherman, B.T., et al. 2009). Pathways with Benjamini & Hochberg 
adjusted p < 0.05 and FDR < 0.05 were accepted as being significantly altered. 
Intact glycopeptide analysis was performed manually using Xcalibur v2.2 (Thermo Scientific) with aid 
from Byonic v.2.16.11 (Protein Metrics Inc, Cupertino, CA) (Lee, L.Y., Moh, E.S., et al. 2016). In short, 
the following Byonic search parameters were used: The protease cleavage specificity was trypsin (fully 
specific) with a maximum of one missed cleavage, the precursor ion mass tolerance was 10 ppm, the 




oxidation of Met was a variable modification. The glycan search space used to identify intact N- and 






Results and Discussion 
GM-CSF differentiation of human monocytes to macrophages is one of the most extensively used 
techniques to derive mature macrophages for biochemical and biomedical research. Given that in 
humans, tissue-derived macrophages are frequently not available, monocyte-derived macrophages 
represent an important tool for the analysis of macrophage function. These monocytes are commonly 
matured using the method described in this work and on day 6-7 stimulated with inflammatory stimuli 
such as LPS or infected with pathogens such as M. tuberculosis. While this model does not perfectly 
recapitulate the in vivo situation with tissue-resident macrophages or tissue inflammatory monocytes, 
it provides a context to investigate changes in these cells in response to specific stimuli that would 
otherwise not be available to researchers in most instances. Investigation and characterisation of the 
glycosylation changes that occur during conventional monocyte differentiation, in the absence of 
strong pro- or anti-inflammatory stimuli such as infection, was the aim of this study. 
To this end, this study has generated the first high-definition longitudinal map of the protein N- and 
O-glycome associated with the maturation of human macrophages from healthy CD14+-monocytic 
precursors. A conventional differentiation protocol used widely in immunobiology employing GM-CSF-
mediated maturation of primary CD14+-monocytes over seven days was used with longitudinal 
sampling at day 0, 1, 3, 5, and 7, Figure 1A. We used our recently improved label-free glycomics 
method employing post-column make-up flow in conjunction with PGC-LC-MS/MS operating in 
negative-ion mode to obtain quantitative fine structure information of the N- and O-glycome of 
maturing macrophages at high sensitivity with temporal resolution (Hinneburg, H., Chatterjee, S., et 
al. 2019). Label-free quantitative LC-MS/MS-based proteomics and glycopeptide analysis as well as 
lectin flow cytometry and microscopy provided additional molecular level and morphological 
information of the differentiation process. 
 




The morphology of the CD14+-monocyte population was monitored by light microscopy during 
differentiation, Figure S1. The maturing cells acquired adhesion properties by day 1. The 
transformation to a more heterogeneous and voluminous cell type with cellular extensions and 
irregular morphology was not observed until day 5. The characteristic pseudopodia-rich macrophage 
morphology indicating terminal macrophage maturation was observed from day 5 and 6, but not fully 
reached until day 7. 
Quantitative proteomics confidently identified a total of 2,600 human proteins across the monocyte-
macrophage development stages, Table S1. Functional annotation using DAVID identified a number 
of expected protein pathways including enriched pathways related to classical metabolic and immune 
processes such as signal transduction, redox processes, cell-cell adhesion, protein transport and innate 
immune/inflammatory responses, Table S2 (Kraft-Terry, S.D. and Gendelman, H.E. 2011, Sander, J., 
Schmidt, S.V., et al. 2017). Despite rigorous washing of the ex vivo cultured cells prior to lysis and 
profiling, additional sets of proteins were detected including 1,140 proteins ambiguously assigned as 
either of human or bovine origin and 101 proteins arising unambiguously from a bovine source, Table 
S3-S4. The bovine protein interference, which possibly originated from the FBS, a critical culture 
medium component for the ex vivo differentiation protocol, was assessed by protein intensity to be 
of lower abundance than the detected human proteins, and was found to remain constant over the 
differentiation process, as shown for three abundant bovine proteins i.e. bovine pancreatic trypsin 
inhibitor, bovine F-actin-capping protein subunit beta and bovine fetuin, Figure S2 and Table S5-S6. 
The bovine FBS interference, which may have contributed to, but not longitudinally skewed, the 
glycome profiles reported herein, may be a functional, yet still unwanted consequence, of the 
phagocytotic nature of monocytes and macrophages. 
Since the aim of the proteome profiling was to validate the monocyte-to-macrophage transition rather 
than to map the deep proteome of monocyte-macrophage populations (Kraft-Terry, S.D. and 




confirmed to originate from a human source for the functional analysis and for the subsequent 
exploration of the monocyte-macrophage glycoproteome. 
Unsupervised hierarchical clustering of a subset of 124 proteins identified as being differentially 
expressed across the monocyte-to-macrophage transition (p < 0.05, see Table S7 for data and 
statistics) showed that the day 0-3 proteome expression was distinctly different from the day 5-7 
proteome expression, Figure S3. The glycomics data to some extent recapitulated these early-to-late 
maturation stage differences (see below). Pathway analysis using the 124 differentially expressed 
proteins as input demonstrated that phagocytosis (17.2-fold enrichment, adjusted p < 0.02) and cell 
adhesion (7.5-fold enrichment, adjusted p < 0.04) were, as expected, significantly enriched biological 
processes associated with macrophage maturation, Table S8-S10. 
Further, the proteomics data demonstrated a maturation stage-dependent expression of specific 
proteins previously associated with human monocytes and macrophages. For example, proteins 
known to be a molecular feature of monocytes were found to be down-regulated with progressive 
macrophage maturation including neutrophil elastase (p = 0.0021), cathepsin G (p = 0.000097) and 
myeloperoxidase (p = 0.0043) (Kargi, H.A., Campbell, E.J., et al. 1990, Khan, A.A., Alsahli, M.A., et al. 
2018), while proteins known to be enriched in macrophages concomitantly displayed increased 
expression levels with progressive phagocyte maturation including apolipoprotein E (p = 0.0032, all 
two-tailed paired student’s t-test, day 0 vs. day 7) (Tedla, N., Glaros, E.N., et al. 2004, Zhang, W.Y., 
Gaynor, P.M., et al. 1996), Figure S4. These expected expression patterns served to further validate 
the GM-CSF-based macrophage maturation. 
Relevant to our observation, human M2-macrophages arising from ex vivo stimulation of primary 
monocytes with macrophage colony-stimulating factor were previously reported to undergo 
significant mid-stage (day 3 to day 5) proteome changes involving several altered biological processes 
i.e. cell-to-cell signalling/interaction, cellular function/maintenance, free radical scavenging, 




observation of similar yet distinctly different proteome changes underpinning the functionally 
different M1- and M2-macrophages is not surprising giving their common progenitor and their in vivo 
plasticity and interchangeability (Italiani, P. and Boraschi, D. 2014). 
 
Mannose- and sialic acid-rich N-glycosylation features of human CD14+-monocytes and macrophages 
Glycomics profiling revealed an extensive N-glycome heterogeneity of the studied monocyte-
macrophage cell populations. In total, 102 N-glycans comprising many biosynthetically related isomers 
spanning 54 monosaccharide compositions were quantified, see Supplementary data 1 for annotated 
fragment spectra of all reported glycans and Table S11-S27 for other supporting glycomics data. The 
mannose-terminating glycans comprising both the common oligomannosidic (29.8%-35.7%) and the 
less reported paucimannosidic (22.1%-30.8%) N-glycan types were found to be consistently abundant 
across all samples, Figure 1B. In particular, M6-M9 (Man6-9GlcNAc2) and M2(F) (Man2GlcNAc2Fuc0-1) 
were abundant N-glycan species. The distinct PGC-LC elution pattern and the informative negative 
polarity CID-MS/MS spectral evidence (see Supplementary data 1) as well as multiple observations at 
the glycopeptide level (see below), collectively confirmed that the less reported paucimannosidic N-
glycans are not mass spectrometry artefacts. Instead, it is clear that this non-conventional glycan class 
is carried by human glycoproteins residing in intracellular compartments and are generate through an 
elaborate truncation pathway involving the action of N-acetyl-β-hexosaminidases and possibly 
linkage-specific α-mannosidases that is distinctly different from the conventional anabolic 
glycosylation machinery in the ER-Golgi-based secretory pathway (Tjondro, H.C., Loke, I., et al. 2019). 
These truncated glycoproteins are known to arise from highly processed glycoprotein intermediates 
generated by the action of GlcNAc-transferase I and in some cases fucosyltransferase VIII, but the 
timing and the cellular location of the final trimming events catalysed by these glycoside hydrolases 
and indeed the function of paucimannosidic proteins in monocytes and macrophages remain elusive. 
Further, the highly branched 2,3/6-sialylated complex-type N-glycans mostly comprising bi- and tri-




glycan type within the monocyte-macrophage N-glycome (27.6%-39.1%). For the sialylated N-glycans 
where the two prominent sialyl-linkage types (α2,3- or α2,6-) could confidently be assigned (the case 
for all mono- and bi-antennary N-glycans), the longitudinal N-glycome profiling demonstrated that 
α2,6-sialylation (8.0%-10.4%) consistently was higher than the α2,3-sialylation (2.4%-3.5%). The 
quantitative glycomics data also showed that the relative expression levels of these two sialyl-linkage 
isomers remained unchanged over the maturation course, Table S19. 
While PGC-LC-MS/MS is a recognised gold standard to obtain quantitative glycomics data with fine 
structure resolution, a method used by many laboratories world-wide (Chatterjee, S., Lee, L.Y., et al. 
2019), the approach has limitations that are important to point out. Similar to other glycoanalytical 
techniques, PGC-LC-MS/MS often leaves some structural ambiguity of the identified glycans, 
particularly of the glycosidic linkage types and branch points of larger complex glycans that typically 
exist as many glycan isomers with identical masses. Another shortcoming is that the biosynthetically 
“extreme” glycans, for example, the highly truncated chitobiose core-type N-glycans only containing 
one or few monosaccharide residues of low molecular mass or very large, branched, and/or acidic 
glycans may go undetected in PGC-LC-MS/MS glycomics experiments due to poor or irreversible PGC-
LC retention and due to limitations in the detection of such analytes that may be outside the optimal 
m/z detection window of the mass spectrometer (Abrahams, J.L., Packer, N.H., et al. 2015). Indeed, 
such difficult-to-study N-glycans including glycans displaying poly-N-acetyllactosamine extensions and 
highly branched sialyl Lewis-type structures may functionally be involved in or simply passively mark 
the monocyte differentiation process and should thus be explored in the context of monocyte-
macrophage maturation once the available technologies allow for their accurate profiling. 
Supporting our N-glycome profiling data, Delannoy and colleagues previously used MALDI-TOF-
MS/MS profiling of permethylated glycans to demonstrate that undifferentiated monocytic THP-1 
cells (resembling our CD14+-monocytes at day 0) abundantly express oligomannosidic-type N-glycans 




(Delannoy, C.P., Rombouts, Y., et al. 2017). We identified 28 of the 40 structures (70.0%) reported in 
their study, Table 1. The paucimannosidic-type N-glycans were, however, not reported in their study 
possibly due to the chosen analytical strategy, which may have precluded the detection of the low-
mass glycans. 
 
Figure 1. High-resolution N- and O-glycome map of maturing macrophages using quantitative 
glycomics. A) Overview of the experimental design used to generate a longitudinal map of the protein 
N- and O-glycome associated with GM-CSF-mediated monocyte-to-macrophage maturation over 
seven days from healthy donors using label-free quantitative glycomics and accompanying 
proteomics, glycopeptide analysis, microscopy and lectin flow cytometry. B) Overview of the 
longitudinal glycome data focusing on the abundantly expressed N- and O-glycans over the five 




In another related study, we recently characterised the N-glycome of phorbol 12-myristate 13-
acetate-differentiated THP-1 cells (resembling the day 7 macrophages of this study) using PGC-LC-
MS/MS (Hare, N.J., Lee, L.Y., et al. 2017). The high abundance of oligomannosidic- (~40%) and 
paucimannosidic (~50%) N-glycan types as well as complex-type tri- and tetra-antennary sialoglycans 
with variable core fucosylation (~10%) of differentiated THP-1 cells agreed well with the macrophage 
N-glycome phenotype reported herein. In fact, the same 18 N-glycans were reported by both studies, 
but notably a much greater coverage of the N-glycome was achieved in this study (64 vs. 18 
compositions) as a likely result of the improved sensitivity of the employed glycome profiling strategy 
(Hinneburg, H., Chatterjee, S., et al. 2019). 
Finally, Bax and colleagues (Bax, M., García-Vallejo, J.J., et al. 2007) used MALDI-TOF-MS/MS to profile 
permethylated N-glycans of blood-derived CD14+-monocytes supplemented with GM-CSF 
(corresponding to day 5 cells of this study). The authors reported a profile dominated by 
oligomannosidic- and highly branched complex-type sialo-N-glycans. We identified 23 of the 48 
structures (47.9%) reported in their study, which also underestimated the presence of the 
paucimannosidic-type glycans relative to our PGC-LC-MS/MS-based profiling. Taken together, this 
literature comparison adds confidence to our N-glycome data and demonstrates that our high-
definition longitudinal whole cell glycome map obtained from maturing primary cell populations has 
expanded the coverage of the monocyte-macrophage N-glycome. 
 
Table 1. Comparison of the N-glycans observed in this study to the monosaccharide compositions 
reported in three related glycomics studies of primary and THP-1 monocyte-macrophage populations 
(Bax, M., García-Vallejo, J.J., et al. 2007, Delannoy, C.P., Rombouts, Y., et al. 2017, Hare, N.J., Lee, L.Y., 
et al. 2017). xxxx, single most abundant N-glycan composition; xxx, top 2-5; xx, top 6-10; x, identified 
and quantified glycan composition of relatively low abundance; (x), identified, but not quantified 
glycan detected at trace levels. #No quantitative data available *Ethyl-esterified N-glycans (MS 
intensities, only top 6). Italics, not detected in this study. Please note that the glycan fine structures 































 HexNAc2dHex1 x  
  
 Hex1HexNAc2 x  
  
 Hex1HexNAc2dHex1 x  
  
 Hex2HexNAc2 xxx xx 
  
 Hex2HexNAc2dHex1 xxx xxxx 
  
 Hex3HexNAc2 xx xxx 
  
 Hex3HexNAc2dHex1 x xxx 
  
Oligomannosidic-type N-glycans 
 Hex4HexNAc2 x  
  
 Hex5HexNAc2 xx xx xx x 
 Hex6HexNAc2 xxx xx xxx x 
 Hex7HexNAc2 xx xx xxx x 
 Hex8HexNAc2 xx xxx xxx x 
 Hex9HexNAc2 x xxx xxxx x 
 Hex10HexNAc2 x x xxx 
 
Hybrid/complex-type N-glycans 
 Hex5HexNAc3 x  
  
 Hex6HexNAc3 x x 
 
x 
 Hex5HexNAc4 x x 
 
x 
 Hex5HexNAc3NeuAc1 x x 
  
 Hex6HexNAc3dHex1 x  
  
 Hex5HexNAc3dHex1NeuAc1 x  
  
 Hex6HexNAc3NeuAc1 x x 
  
 Hex7HexNAc3NeuAc1 x  
  






 Hex3HexNAc3 x  
  
 Hex3HexNAc3dHex1 x x x 
 
 Hex4HexNAc3 x  x 
 
 Hex3HexNAc4 (x)  
  
 Hex4HexNAc3dHex1 x  x 
 
 Hex3HexNAc4dHex1 x x 
  
 Hex3HexNAc5hex1 x  x 
 
 Hex4HexNAc4dHex1 x  
  







 x x 
 Hex6HexNAc5 x  x 
 





 Hex7HexNAc6dHex1 x  x x 
 Hex4HexNAc3NeuAc1 x  
  
 Hex4HexNAc3dHex1NeuAc1 x  
  
 Hex4HexNAc4NeuAc1 x  
  
 Hex4HexNAc4dHex1NeuAc1 x  
  
 Hex5HexNAc4NeuAc1 x  x x 
 Hex5HexNAc4dHex1NeuAc1 x xx x x 
 Hex5HexNAc4dHex2NeuAc1 
 
 x x 
 Hex5HexNAc4dHex2NeuAc2 
 
 x x 
 Hex5HexNAc4NeuAc2 xxx  x x 





 Hex5HexNAc4NeuAc3 (x)  
  







 Hex6HexNAc5NeuAc1 x  x x 
 Hex6HexNAc5dHex1NeuAc1 x  x x 
 Hex7HexNAc6NeuAc1 (x)  x x 
 Hex7HexNAc6NeuAc2 
 
 x x 
 Hex7HexNAc6NeuAc3 
 
 x x 





































 Hex7HexNAc6dHex1NeuAc2 x  x x 
 Hex6HexNAc5NeuAc4 xx  
  
 Hex7HexNAc6NeuAc4 (x)  x x 
 Hex6HexNAc5dHex1NeuAc3 x  
  
 Hex3HexNAc3NeuAc1 x  
  
 Hex6HexNAc5NeuAc5 (x)  
  
 Hex5HexNAc5NeuAc2 x  
  
 unknown(1) x  
  
 unknown(2) x  
  
 Hex7HexNAc6dHex1NeuAc3 (x)  x x 

































































Compositions identified 64 18 40 48 
Glycans found in this study  18 28 23 




GM-CSF-mediated macrophage maturation induces only subtle whole cell N-glycome changes 
The whole cell N-glycome expressed by CD14+-monocytes and mature macrophages was found to be 
surprisingly similar as visually illustrated by a heat map plotting the relative N-glycan abundances over 
the differentiation course, Figure 2A. Only ten, seemingly biosynthetically unrelated, structures of a 
total of 102 N-glycans displayed a significantly altered expression over the maturation process 
including glycans belonging to the oligomannosidic-, hybrid-, and complex sialylated-type (all p < 0.05, 
two-tailed paired student’s t-test, day 0 vs. day 7), Table S12A. 
The N-glycan types were quantitatively monitored over the seven-day differentiation, Figure 2B(I-V). 
In concordance with a previous observation (Delannoy, C.P., Rombouts, Y., et al. 2017), the abundant 
mannose-terminating N-glycans (i.e. paucimannosidic- and oligomannosidic-type N-glycans) were 
reduced from 30.8% and 34.6% (day 0) to 23.1% and 29.8% (day 7), respectively, while the complex 
sialylated N-glycans concomitantly increased from 27.6% (day 0) to 39.1% (day 7), see Table S13-S19. 
None of these alterations, however, reached statistical significance possibly due to significant inter-
donor variations within the population of isolated CD14+-monocytes and in the subsequent 
differentiation process. 
The distribution of the sialyl-linkage type (α2,3/6-) and the levels of core (α1,6-) fucosylation were also 
monitored. Only the expression of core fucosylated N-glycans was significantly altered in macrophages 
(20.1% ± 2.2%) relative to CD14+-monocytes (31.5% ± 4.3%, calculated out of the entire N-glycome, p 
< 0.05, two-tailed paired student’s t-test, day 0 vs. day 7), Figure 2B(VI), Table S20 and Table S14A. A 
significant lower expression of core fucosylation of day 7 macrophages (29.0% ± 5.4%) compared to 
day 0 monocytes (48.1% ± 3.4%) was also found when calculating the relative level of core fucosylation 
out of only the N-glycan types that are biosynthetically capable of receiving this type of modification 
(p < 0.05, two-tailed paired student’s t-test, day 0 vs. day 7), Table S20A. The subtle N-glycome 
alterations were largely restricted to day 5-7 of the maturation process in accordance with the 





Figure 2. Longitudinal whole cell N-glycome profiling of maturing human macrophages. A) Heat map 
plotting the relative intensities (log10 scale) of all identified 102 N-glycans over the seven-day 
macrophage maturation process. Note that the fine structures of the N-glycans, here represented as 
monosaccharide compositions due to space constraints, have been elucidated, see Table S11. *Only 
10 N-glycan structures (consecutively numbered and depicted) showed significantly changed 
expression levels during maturation (p < 0.05, two-tailed paired student’s t-test, day 0 vs. day 7, n = 
3). B) Donor-specific longitudinal monitoring of the N-glycan types (I-V) and another abundant 
glycosylation feature i.e. core fucosylation (VI). These glycan features were calculated and plotted as 
a proportion of the total N-glycome. Black lines represent the average relative levels the three donors 
at each sampling point. *p < 0.05, two-tailed paired student’s t-test, day 0 vs. day 7, n = 3. Data is 






Quantitative proteomics and glycopeptide analysis support a constitutively active truncation pathway 
in monocytes and macrophages 
Our glycomics data indicated constitutively high expression of paucimannosidic-type N-glycosylation 
in both monocytes (day 0: 30.8% ± 6.5%) and mature macrophages (day 7: 23.1% ± 0.5%). 
Paucimannosylation remains an under-reported and still debated type of protein N-glycosylation in 
human glycobiology (Loke, I., Kolarich, D., et al. 2016, Tjondro, H.C., Loke, I., et al. 2019). We and 
others have recently reported that this type of N-glycosylation is a prominent feature of neutrophil-
mediated infection and immunity (Loke, I., Ostergaard, O., et al. 2017, Loke, I., Packer, N.H., et al. 
2015, Thaysen-Andersen, M., Venkatakrishnan, V., et al. 2015), cancer (Becker, Y., Forster, S., et al. 
2019, Chatterjee, S., Lee, L.Y., et al. 2019, Kaprio, T., Satomaa, T., et al. 2015, Sethi, M.K., Kim, H., et 
al. 2015) and cellular development (Dahmen, A.C., Fergen, M.T., et al. 2015), but so far not in primary 
monocyte-macrophage cell populations. 
Consequently, we interrogated our proteomics data for intact glycopeptides to prove that the 
paucimannosidic-type N-glycans are in fact carried by human proteins commonly expressed by 
monocytes and macrophages. As exemplified by two intact N-glycopeptides identified with high 
confidence from HCD-MS/MS spectral evidence, paucimannosidic-type N-glycans, in particular, M2F 
were found to be carried by several anti-microbial monocyte-derived proteins including neutrophil 
elastase (P08246) and myeloperoxidase (P05164) (Kargi, H.A., Campbell, E.J., et al. 1990, Khan, A.A., 
Alsahli, M.A., et al. 2018, Nicholls, S.J. and Hazen, S.L. 2005), Figure S5A-B. Adding further support, 
these two immune-related glycoproteins were previously reported to carry paucimannosidic-type N-
glycosylation signatures, in particular Man2GlcNAc2Fuc1 (M2F), when studied from a neutrophil origin 
(Loke, I., Packer, N.H., et al. 2015, Ravnsborg, T., Houen, G., et al. 2010, Reiding, K.R., Franc, V., et al. 
2019, Van Antwerpen, P., Slomianny, M.C., et al. 2010). 
The quantitative proteomics data was then explored in order to assess the relative expression levels 




paucimannosidic proteins i.e. N-acetyl-β-hexosaminidase subunit α (P06865), N-acetyl-β-
hexosaminidase subunit β (P07686) and lysosomal α-mannosidase (O00754) (Tjondro, H.C., Loke, I., 
et al. 2019). High and unaltered expression levels of these glycoside hydrolases over the entire seven-
day macrophage maturation scheme were observed i.e. N-acetyl-β-hexosaminidase subunit α, day 0: 
3.9 x 108 ± 7.6 x 107, day 1: 6.9 x 108 ± 5.9 x 108, day 3: 2.4 x 108 ± 6.1 x 107, day 5: 4.6 x 108 ± 7.6 x 107, 
day 7: 4.2 x 108 ± 5.9 x 107, N-acetyl-β-hexosaminidase subunit β, day 0: 1.4 x 109 ± 3.5 x 108, day 1: 9.6 
x 108 ± 3.5 x 108 , day 3: 1.3 x 109 ± 1.2 x 108, day 5: 1.3 x 109 ± 2.2 x 108, day 7: 1.4 x 109 ± 7.8 x 107), 
lysosomal α-mannosidase, day 0: 1.3 x 109 ± 7.5 x 108, day 1: 1.1 x 109 ± 7.5 x 108, day 3: 1.4 x 109 ± 2.6 
x 108, day 5: 2.1 x 109 ± 4.1 x 108, day 7: 2.4 x 109 ± 3.8 x 108, all average ± SD protein intensity values, 
Table S5-S6. Thus, the quantitative proteomics data supports that the truncation pathway is 
constitutively active in both monocytes and macrophages providing a mechanistic explanation for the 
high levels of paucimannosidic proteins observed in these cell populations. The glycomics profile 
indicated a slightly reduced expression of paucimannosidic N-glycans during macrophage 
differentiation (day 0: 30.8% ± 6.5% vs. day 7: 23.1% ± 0.5%). This reduction, which did not reach 
statistical significance, may mechanistically be explained by a reduced protein level expression of the 
paucimannose-decorated proteases and other key glycoproteins predominantly expressed in 
monocytes rather than in macrophages i.e. neutrophil elastase, cathepsin G, and myeloperoxidase, 
Figure S4, as opposed to changes per se of the glycosylation enzymes catalysing the truncation 
pathway and the resulting N-glycan profile of these proteins, a hypothesis requiring further 
experimental testing. 
Many other glycosylation enzymes involved in the formation or catabolism of N-glycoproteins were 
also identified and longitudinally monitored by the quantitative proteomics data including several 
other glycoside hydrolases i.e. β-galactosidase (P16278), tissue α-L-fucosidase (P04066), lysosomal α-
glucosidase (P10253), α-galactosidase A (P06280), α-N-acetylglucosaminidase (P54802), Golgi α-
mannosidase II (Q16706), glucosidase II subunit α (Q14697) and β (P14314), mannosyl-oligosaccharide 




(P61803) and UDP-glucose:glycoprotein glucosyltransferase 1 (Q9NYU2) as well as lectins involved in 
the glycoprotein synthesis and/or function i.e. IGF2R (P11717), galectin-1 (P09382), galectin-3 
(P17931), galectin-9 (O00182), malectin (Q14165), C-type mannose receptor 2 (Q9UBG0), Table S1. 
With the exception of MOGS involved in the processing of the Glc3Man9GlcNAc2 precursor after 
transfer to nascent glycoproteins, the expression of none of these biosynthetic enzymes and receptors 
were significantly altered during the macrophage maturation process (all p ≥ 0.05, two-tailed paired 
student’s t-test, day 0 vs. day 7) thereby providing some support for a relatively constant expression 
of the N-glycome during the monocyte-to-macrophage transition. However, it is important to note in 
this context that the human glycosylation machinery comprises more than 200 glycosylation enzymes 
(Nairn, A.V., Aoki, K., et al. 2012), and that many of the glyco-enzymes expressed at lower abundance 
were neither identified nor quantified in this study. Adding to this, Delannoy and colleagues have 
previously reported that the transcript level of several key glycosylation enzymes are in fact elevated 
upon differentiation of THP-1 macrophages including ST3GAL5, MGAT1, MGAT5, b4GALT1, FUT8 and 
NEU1 (Delannoy, C.P., Rombouts, Y., et al. 2017). Modulation of the glycosylation machinery during 
macrophage maturation was also suggested by other groups (Kohro, T., Tanaka, T., et al. 2004, 
Trottein, F., Schaffer, L., et al. 2009). Hence, dedicated studies using targeted or system-wide analysis 
of enzymes forming the glycosylation machinery either at the transcript level (i.e. quantitative PCR or 
RNASeq) or the protein level (i.e. parallel-reaction monitoring or data-dependent acquisition 
proteomics) are required to fully understand how the glycosylation machinery is affected during the 
maturation of primary macrophages. 
 
Lectin flow cytometry indicates cell surface glycan remodelling upon macrophage maturation 
To complement the whole cell glycomics data, we performed cell surface analysis of the glycoepitope 
expression of the maturing CD14+-monocytes using lectin flow cytometry employing ConA and WGA, 




N-glycans and β-GlcNAc-/α-NeuAc-epitopes, respectively, Figure 3. Strong cell surface reactivity of 
both lectins, significantly above the background fluorescence of unstained cells, was observed for the 
monocyte-macrophage cell populations. Interestingly, differentiation of monocytes into macrophages 
was accompanied by a significant increase in ConA binding to mature macrophages on day 7. Attempts 
to perform lectin flow cytometry using Mannitou-IgM, an antibody known to recognise 
paucimannosidic epitopes (Becker, Y., Forster, S., et al. 2019), to probe for a cell surface presentation 
of paucimannosidic proteins were hampered by significant clumping/aggregation of cells as a likely 
result of the multi-valent binding properties of IgM (data not shown). The basis for the elevated ConA 
reactivity in day 7 macrophages therefore remains unclear. Future lectin flow cytometry experiments 
using Mannitou-IgG or plant lectins able to discriminate between the various classes of mannose-
terminating glycoconjugates and possibly complemented with the use of subcellular fractionation 
techniques or cell surface capture technologies followed by LC-MS/MS-based glycomics are required 
to fully delineate the relative contribution of the oligomannosidic and paucimannosidic proteins to 
the intriguing ConA reactivity to the cell surfaces of mature macrophages as well as the intracellular 
distribution of these glycoproteins. 
Further, a progressive increase in the WGA reactivity was observed during macrophage 
differentiation, reaching significance only at day 5, when compared to undifferentiated monocytes 
(day 0 and 1). The quantitative whole cell glycomics data revealed that a significant proportion of the 
monocyte-macrophage N-glycome comprises α2,3-/α2,6-sialylated complex-type N-glycans (27.6%-
39.1%) and that six of the ten N-glycan structures showing changed expression levels during 
maturation were in fact capped by sialic acid residues (Figure 2A). Such mature sialylated N-glycans, 
as well as the highly sialylated O-glycans (discussed below), are most likely present on the cell surface 
and would thus contribute significantly to the observed WGA signal in the lectin flow cytometry data. 
It remains unexplored if the elevated WGA reactivity at day 5 is a result of an enhanced cell surface 
presentation of α2,3- and/or α2,6-sialylated N- and O-glycan structures by cell surface proteins (or 




sialidase treatment using other plant lectins that recognise these glycoepitopes including SNA, MAL-I 
and MAL-II. 
Considering the importance of the cell surface localised glycoepitopes for immune cell communication 
and the significant glycan remodelling indicated here to be associated with monocyte-macrophage 
differentiation, future studies focusing on delineating the temporal-spatial presentation of glycans on 
the surface during maturation of monocytes with fine structure resolution and efforts attempting to 
understand the mechanisms that drive such glycan remodelling are clearly warranted. 
 
Figure 3. The presentation of cell surface glycoepitopes on differentiating human CD14+-monocytes 
was assessed by WGA and ConA-based lectin flow cytometry (black lines). The signals from unstained 
cells are represented by grey lines. A significant increase in the ConA reactivity was observed at day 7 
compared to all other time points, and in the WGA reactivity at day 5 compared to undifferentiated 
monocytes at day 0 and day 1. MFI, mean fluorescence intensity. Data is plotted as the mean and 
standard error of measurements of cells obtained from three donors. ** p < 0.01, **** p < 0.0001 by 
two-way ANOVA. 
 
Subtle O-glycome changes during macrophage differentiation 
The O-glycomics data allowed profiling of a total of 15 glycans comprising mainly unsubstituted core 
1- and 2-type O-glycans and a few sulfated structures identified at relatively low abundance, Figure 






































4A and Table S21-S23. Annotated spectral data is available documenting the structural details of the 
reported O-glycans, see Supplementary data 1. Quantitative profiling demonstrated that only a single 
O-glycan was significantly altered over the time course i.e. the high abundance 
Gal2GlcNAc1GalNAc1NeuAc2 showed reduced expression with progressive macrophage transition in 
particular during the late stage maturation (p < 0.05, two-tailed paired student’s t-test, day 0 vs. day 
7), Figure 4B (Structure 4) and Table S22-S27. In support of our findings, Bax and colleagues identified 
the same O-glycan signatures and reported Hex1HexNAc1NeuAc1 (presumably Gal1GalNAc1NeuAc1) as 
the most abundant structure of maturing human CD14+-monocytes (resembling our day 5 cells) using 
MALDI-TOF-MS/MS profiling and interestingly also reported a decrease of core 2-type O-glycans 
during GM-CSF-mediated differentiation of human CD14+-monocytes to dendritic cells (Bax, M., 
García-Vallejo, J.J., et al. 2007). By grouping the observed O-glycan structures according to their core 
types, we found that both core 1- and core 2-type O-glycans were significantly altered in expression 
during macrophage differentiation (p = 0.048, up-regulation and p = 0.048 down-regulation, 
respectively, two-tailed paired student’s t-test, day 0 vs. day 7), which collectively generated a 
substantial difference in the core 1-core 2 O-glycan ratio from day 0 (6.4) relative to day 7 (12.4) cells, 
Table S22A. Conversely, the level of O-glycan sialylation remained largely unchanged over the 
differentiation course i.e. day 0 (2.5%:62.4%:35.1%) and day 7 (1.1%:65.6%:33.3%) (written as the 
average relative proportion of asialo:monosialo:diasialo-O-glycans), demonstrating that the lower 
level of the disialylated core 2-type O-glycan observed at day 7 arises from a general shift towards the 
core 1-type O-glycosylation rather than a reduced O-glycan sialylation in day 7 macrophages relative 
to day 0 monocytes. These subtle alterations in the relative distribution of the observed O-glycans 
have been plotted on the well-established O-glycosylation biosynthetic pathway, Figure S6 (Kudelka, 
M.R., Ju, T., et al. 2015). Importantly, several intact core 1- and core 2-type O-glycopeptides from 
human glycoproteins of monocyte-macrophage origin including the macrophage mannose receptor 1 
(UniProtKB, P22897) were identified in the proteomics data providing support for the O-glycomics 




Taken together, these observations indicate that the biosynthetic pathways for O-glycoproteins are 
altered in subtle ways during macrophage maturation, a hypothesis we unfortunately were unable to 
confirm using our proteomics data sets. The proteomics experiments only detected a few 
glycosylation enzymes involved in O-glycoprotein biosynthesis and catabolism, which all showed a 
stable expression across the differentiation period, including α-N-acetylgalactosaminidase (P17050), 
polypeptide N-acetylgalactosaminyltransferase (Q10471), GDP-fucose protein O-fucosyltransferase 
(Q9H488) and carbohydrate sulfotransferase (Q9NPF2) (data not shown). The glycosylation enzymes 
directly involved in core 1- and core 2-type O-glycoprotein synthesis, the abundant O-glycan features 
observed in the monocyte-macrophage O-glycome, e.g. core 2/core 4 beta-1,6-N-






Figure 4. Longitudinal O-glycome profiling of maturing human macrophages. A) Relative abundance 
of the identified O-glycans over the seven-day differentiation process. Data is plotted as mean ± SD, n 
= 3. *p < 0.05, two-tailed paired student’s t-test (day 0 vs. day 7). Sul: Sulfate. B) Donor-specific 
longitudinal monitoring of four abundant O-glycan structures (Structure 1-4, also indicated in panel 
A). The black lines represent the average of three donors at each sampling point. Data points are 





Biological importance and individual-specific glycome variation of human monocyte-macrophages 
Complex carbohydrates carried by intra- and extracellular glycoproteins are recognised by a spectrum 
of glycan-binding proteins including endogenous lectins and microbial adhesins that concertedly 
mediate and modulate diverse functions within the diverse cell types of the innate immune system 
not least monocytes and macrophages (Baum, L.G. and Cobb, B.A. 2017, Schnaar, R.L. 2016, Zhou, J.Y., 
Oswald, D.M., et al. 2018). Given their distinct functions in vivo and highly different tissue 
environments (Murray, P.J. 2017), we herein set out to document the N- and O-glycosylation features 
expressed by monocytes and macrophages expecting that the profiling would reveal distinct glycome 
expression patterns despite the cellular relatedness between these two cell types. Forming the basis 
of this hypothesis, O-glycan remodelling during B cell differentiation (Giovannone, N., Antonopoulos, 
A., et al. 2018), N- and O-glycosylation alterations during in vitro differentiation of THP-1 monocytes 
to macrophage-like cells (Delannoy, C.P., Rombouts, Y., et al. 2017), and glycosylation differences 
between immature monocyte-derived dendritic cells and their mature counterpart (Bax, M., García-
Vallejo, J.J., et al. 2007) have previously been reported. 
Thus, our quantitative whole cell glycomics data presented in this study indicating relative stable 
expression of the cellular protein N- and O-glycome during macrophage maturation may, on the face 
of it, appear surprising given the known dynamics and physiology-dependent nature of the 
mammalian glycosylation machinery (Moremen, K.W., Tiemeyer, M., et al. 2012). Mature 
macrophages may, however, still, in effect, display a unique glycosylation phenotype that is distinctly 
different from their monocytic precursors by manipulating the glycoproteome and/or alter the spatial 
arrangement of the expressed glycome, details not presently captured by conventional whole cell 
glycomics experiments. Our proteomics data in fact indicated a maturation stage-dependent 
proteome expression that corroborated other proteomics literature produced from monocyte-
macrophage cell populations indicating strong protein level regulation during macrophage 




changing the glyco(proteo)me expression is also a recognised mechanism used by cells to alter their 
“glycan-code” (Moremen, K.W., Tiemeyer, M., et al. 2012). Our observation of a highly increased ConA 
reactivity to mature macrophages (day 7) using lectin flow cytometry despite a concomitant reduction 
in the expression of mannose-terminating N-glycans within the cellular N-glycome may represent an 
example of temporal-spatial glycan “remodelling”. The mannose-rich glycoepitope expression 
patterns on the surfaces of mature macrophages may be particularly interesting given the diverse 
repertoire of mannose-recognising lectins displaying both endocytic and signalling capacity including 
the macrophage mannose receptor 1 (P22897) and C-type mannose receptor 2 (Q9UBG0) (Loke, I., 
Kolarich, D., et al. 2016). The identity and involvement of these surface-located manno-conjugates in 
the diverse functions carried out by monocytes and macrophages require further exploration. It 
should also be pointed out that other glycoconjugate classes not profiled in this study including 
glycosphingolipids (e.g. GM3) and O-mannose and O-GlcNAc-type modifications as well as the various 
classes of proteoglycans and glycosaminoglycans may contribute to the glycan remodelling 
underpinning the monocyte-to-macrophage transition and may therefore be important glycosylation 
features defining the “glycosylation phenotype” pertaining to monocytes and macrophages, aspects 
that require dedicated follow-up studies using tailored analytical approaches. 
Noteworthy, relatively large donor-to-donor glycome and proteome variations were observed 
throughout this profiling study possibly reflecting a considerable physiology-dependent or inherited 
heterogeneity of the isolated CD14+-monocyte populations used for analysis in this study, and, further, 
indicates that multiple macrophage differentiation pathways may exist. Pronounced cellular and 
molecular heterogeneity may represent a general feature of stem and progenitor cells harbouring 
differentiation potential, and may thus be a feature also of other immune and non-immune cell types 
(Corfield, A.P. and Berry, M. 2015, Tarique, A.A., Logan, J., et al. 2015). Notably, the inter-donor 
variation was pronounced in the undifferentiated CD14+-monocytes and in the early-/mid-stage 
maturation process while convergence of the molecular heterogeneity was observed at the 




glycan convergence in Figure 4B. Given the significant inter-donor variation reported herein, 
experimental designs using longitudinal measurements of monocyte-macrophage populations from 
the same donor rather than comparing cell populations between donors appears to be a more 
informative approach. Follow-up studies using a larger cohort of healthy donors and/or repeat 
sampling from the same set of individuals are required to further explore this intriguing biological 
variation and to determine if the GM-CSF-mediated ex vivo convergence of macrophages observed in 
this study is reflected in macrophage populations in vivo, for example from macrophage-rich 
atherosclerotic plaques or alveolar or hepatic macrophages obtained from patients undergoing lung 
or liver transplantation or lobectomy. Further, characterisation of macrophage subpopulations and 
associated changes in glycoimmunological traits during strong pro- and anti-inflammatory stimulation 
(M1- and M2-macrophage polarisation, respectively) should also be subjected to future investigations. 
In conclusion, this high-resolution system-wide map of the protein N- and O-glycome associated with 
healthy monocyte-to-macrophage transition, the most detailed to date, aids our understanding of the 
molecular makeup of two important types of innate immune cells and forms an essential point of 
reference for future glycoimmunological studies involving human monocytes and macrophages. 
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ACN: acetonitrile; AGC: automatic gain control; CID: collision-induced dissociation; FBS: foetal bovine 
serum; FA: formic acid; Fuc: fucose/fucosyl; Gal: galactose/galactosyl; GalNAc, N-
acetylgalactosamine/N-acetylgalactosaminyl; GlcNAc: N-acetylglucosamine/N-acetylglucosaminyl; 
GM-CSF: granulocyte-macrophage colony-stimulating factor; HCD: higher-energy collisional 
dissociation; MALDI-TOF: matrix-assisted laser desorption/ionisation-time-of-flight; Man: 
mannose/mannosyl; NeuAc: N-acetylneuraminic acid; PGC-LC-MS/MS: porous graphitised carbon-
liquid chromatography-tandem mass spectrometry; SPE: solid-phase extraction; Sul: sulfate; TEAB: 
triethylammonium bicarbonate; TLR: Toll-like receptor; WGA: wheat germ agglutinin. 
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